August 17, 2018
Rose
A lack of understanding about the disease's physiology makes creating new medicines difficult. “So we hope to revolutionize the way schizophrenics are being treated. … We hope to give these people their lives back," Remy Luthringer, CEO of Boston-based Minerva Neurosciences, tells Stat. In other biotech and pharmaceutical news: companies thrive in Minnesota. And production resumes at a troubled Pfizer plant.
from Kaiser Health News https://ift.tt/2w9d8ch
August 17, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Pediatric Hospice Can Be A Godsend For Heartbroken Parents. But The Facilities Often Struggle To Stay Afloat.- Research Roundup: Surprise Billing; Medicaid Work Requirements; And Decision-Making After Cancer Diagnosis
- State Highlights: Lawsuit Charges USC-Sponsored Plastic Surgeon With 12 Needless Surgeries, Fraud; Advocates Hail Landmark Minnesota Deal To Protect Seniors
- California Investigation Blames PG&E Equipment For Igniting Deadliest Wildfire
- Different Takes: Roe Vs. Wade Isn’t A Decision For The Court To Overturn; Alabama Abortion Ban Protects All Babies, All Life
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment